Using our platform to help precise diagnosis and treatment of cancer
ChosenMedInfo is a medical information platform independently developed by the medical information team focusing on the precise diagnosis and treatment of cancer, it consists of a series of different types of applications and services, including the followings...
- Databases & Knowledgebases
- Application Systems
- Academic Tools
- Technology Blog & Forum
- Life Science APIs
We Provide Best Services
Efficiently aggregate end-to-end core competencies without maintainable ideas. Dynamically foster tactical solutions without enabled value.
Clinical Data Collection
Electronic information collection systems helps us to collect clinical data more efficiently.
Knowledge Data Mining
NLP technology combined with data annotation systems help us to mine knowledge data more quickly.
Issuance of NGS Report
NGS automated reporting systems helps us produce reports more accurately and quickly.
Data analysis tools help us perceive the data and help scientific research and product development.
Data visualization tools help us feel the charm of data more intuitively and reflect the value of data.
To provide efficient and convenient data storage services for ChosenMed and even industry companies.
Full coverage of cancer NGS industry information products
Manually curation combined with natural language processing.
Use NGS data with knowledge to explore more wonderful information.
Data visualization helps us have an intuitive understanding of the data.
Make full use of data to make precise diagnosis and treatment of cancer.
Check Our APPs & Services
ChosenMedInfo consists of a series of different types of applications and services. All applications and services and their related classifications are listed below.
Section 01. Business Systems
Section 04. Scientific Research Systems
Our Latest Publications
ChosenMedInfo contains a series of academic research applications, here are the latest publications.
Comprehensive fundamental analysis and quality management strategy for next-generation sequencing data from cancer genomes
Xiaoyu He, Shanyu Chen, Ruilin Li, Xinyin Han, Zhipeng He, Danyang Yuan, Shuying Zhang, Xiaohong Duan, Beifang Niu
Comprehensive review and evaluation of computational methods for identifying FLT3-internal tandem duplication in acute myeloid leukaemia
Danyang Yuan, Xiaoyu He, Xinyin Han, Chunyan Yang, Fei Liu, Shuying Zhang, Haijing Luan, Ruilin Li, Jiayin He, Xiaohong Duan, Dongliang Wang, Qiming Zhou, Sujun Gao, Beifang Niu
Xinyin Han, Shuying Zhang, Daniel Cui Zhou, Dongliang Wang, Xiaoyu He, Danyang Yuan, Ruilin Li, Jiayin He, Xiaohong Duan, Michael C Wendl, Li Ding, Beifang Niu
DIVIS: Integrated and Customizable Pipeline for Cancer Genome Sequencing Analysis and Interpretation
Xiaoyu He, Yu Zhang, Danyang Yuan, Xinyin Han, Jiayin He, Xiaohong Duan, Siyao Liu, Xintong Wang, Beifang Niu
Identification of a Novel Immune-related CpG Methylation Signature to Predict Prognosis in Stage II/III Colorectal Cancer
Feng Chen, Lijuan Pei, Siyao Liu, Yan Lin, Xinyin Han, Erhong Meng, Xintong Wang, Shuai Hong, Dongliang Wang, Feide Liu, Yang Fei and Guangda Wang
A Signature-Based Classification of Gastric Cancer That Stratifies Tumor Immunity and Predicts Responses to PD-1 Inhibitors
Song Li, Jing Gao, Qian Xu, Xue Zhang, Miao Huang, Xin Dai, Kai Huang, Lian Liu
Identification of JAK2 and FOXM1 expression as novel candidate biomarkers for predicting the benefit of immunotherapy in lung squamous cell carcinoma
Shixin Zhang, Shuai Liu, Xi Liu, Jie Liu, Wei Wu
An integrated model of FTO and METTL3 expression that predicts prognosis in lung squamous cell carcinoma patients
Kun Zhang, Zhaojie Han, Hongmei Zhao, Siyao Liu, Fuchun Zeng
A Supramolecular Nanoparticle of Pemetrexed Improves the Anti-Tumor Effect by Inhibiting Mitochondrial Energy Metabolism
Hui Liu, Chunlei Guo, Yuhong Shang, Lin Zeng, Haixue Jia, Zhongyan Wang
Ya Cui, Zhe Cui, Jianfeng Xu, Dapeng Hao, Jiejun Shi, Dan Wang, Hui Xiao, Xiaohong Duan, Runsheng Chen, Wei Li.
Comprehensive fundamental somatic variant calling and quality management strategies for human cancer genomes
Xiaoyu He, Shanyu Chen, Ruilin Li, Xinyin Han, Zhipeng He, Danyang Yuan, Shuying Zhang, Xiaohong Duan, Beifang Niu.
Shanyu Chen, Xiaoyu He, Ruilin Li, Xiaohong Duan, Beifang Niu.
OASL as a Diagnostic Marker for Influenza Infection Revealed by Integrative Bioinformatics Analysis With XGBoost
Yang Li, Hongjie Liu, Quan Xu, Rui Wu, Yi Zhang, Naizhe Li, Xiaozhou He, Mengjie Yang, Mifang Liang and Xuejun Ma.
Shunan Cao, Fang Zhang, Jianfeng He, Zhongqiang Ji, Qiming Zhou.
Clinicopathological features of tumor mutation burden, Epstein-Barr virus infection, microsatellite instability and PD-L1 status in Chinese patients with gastric cancer
Li Zhang, Yinkui Wang, Zhongwu Li, Dongmei Lin, Yiqiang Liu, Linxin Zhou, Dongliang Wang, Aiwen Wu, Ziyu Li
Comprehensive analysis of immune-related prognostic genes in the tumour microenvironment of hepatocellular carcinoma
Weike Gao, Luan Li, Xinyin Han, Siyao Liu, Chengzhen Li, Guanying Yu, Lei Zhang, Dongsheng Zhang, Caiyun Liu, Erhong Meng, Shuai Hong, Dongliang Wang, Peiming Guo, Guangjun Shi
Huan Li, Lujing Yang, Yumei Lai, Xintong Wang, Xinyin Han, Siyao Liu, Dongliang Wang, Xiaojuan Li, Nana Hu, Yan Kong, Lu Si, Zhongwu Li
Small-Scale Soil Microbial Community Heterogeneity Linked to Landform Historical Events on King George Island, Maritime Antarctica
Yumin Zhang, Lu Lu, Xulu Chang, Fan Jiang, Xiangdong Gao, Yifeng Yao, Chengsen Li, Shunan Cao, Qiming Zhou, Fang Peng
Exploring the roles of substrate-binding surface of the chaperone site in the chaperone activity of trigger factor
Dongjie Fan, Shunan Cao, Qiming Zhou, You Zhang, Lei Yue, Chang Han, Bo Yang, Yu Wang, Zhuo Ma, Lingxiang Zhu, Chuanpeng Liu
Case Report: Dramatic Response to Crizotinib in a Patient with Non-small Cell Lung Cancer Positive for a Novel ARL1-MET Fusion
Qing Ma, Lingping Kong, Diansheng Zhong
Identification of a novel heterozygous germline RAD52 missense mutation in a patient with gallbladder carcinoma: A case report
Wenhu Zhao, Yongjiu Dai, Lei Yue, Jian Gu, Erhong Meng, Dongliang Wang, Siyao Liu, Xinyin Han, Xintong Wang, Guojun Li, Xinzheng Dai
Case Report: Triple Primary Malignant Tumors of the Esophagus, Stomach, and Colon in a Patient With Genetic Analysis
Xiaoli Zhan, Lingzhe He, Kai Song, Shuliang Cao, Erhong Meng, Yuedong Wang
Homozygous deletion of the HLA-B gene as an acquired-resistance mechanism to nivolumab in a patient with lung adenocarcinoma: a case report
He Zhang, Weiwei Dong, Huixia Zhao, Zhiyan Zeng, Fengyun Zhang, Yanyan Hu, Qiuwen Li, Jing Chen, Erhong Meng, Wenhua Xiao
Meet our lovely team
ChosenMedInfo is a multi-functional platform built by a team of different professionals.
CTOFully responsible for system technology
BioinformaticianResearching and Designing
Medical InformaticianResearching and Designing
Data EngineersData collection and processing
NLP EngineersNatural Language Processing
Genetic CounselorsHelp in the reporting systems
If you have any opinion or suggestion on ChosenMedInfo, or if you want to apply for the use of any system, please feel free to contact us, and we will deal with it as soon as we see the message.
C3-1, Jinghai Industrial Park, Beijing, China